Latest1 information on COVID-19

A Registry of Patients With Primary Indeterminate Lesions or Choroidal Melanoma

Recruiting

I'm Interested

Trial ID: NCT03941379

Purpose

The purpose of this observational research study is to follow participants who have been treated with either AU-011 or observation and/or received standard of care therapy while participating in a previous Aura Biosciences clinical research study to assess the long-term safety and effectiveness of AU-011 and standard of care therapy. This study will collect information from procedures conducted as part of routine follow-up eye care and cancer care. Additionally, the registry will collect all adverse events, information about pregnancy and symptomatic overdose.

Official Title

A Registry of Patients With Primary Indeterminate Lesions or Choroidal Melanoma

Eligibility


Inclusion Criteria:

   - Have been clinically diagnosed with primary IL or CM at the time of entry to a
   previous Aura Biosciences sponsored clinical trial.

   - Have received AU-011 or assigned to an observation cohort in a previous Aura sponsored
   clinical trial.

Exclusion Criteria:

   - None

Recruiting

I'm Interested